Traders Recap: Collegium Pharmaceutical, Inc. (NASDAQ:COLL) , BT Group plc (NYSE:BT)

On 4/19/2017, Shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL) closed at $9.88 in last trading day. After noting the initial trading entry at $9.76, it reached to a day’s high of $10.24 and moved to a day’s low of $9.64. The recent daily volume was 464.63 thousand as contrast to it’s an average volume of 409.22 thousand.

Technical Indicators:

The last close of the Collegium Pharmaceutical, Inc. stock reflects that it traded -21.14% from its 50-day moving average of $12.53. The stock traded below -35.13% to its 200-day MA of $15.23. Furthermore, it moved lower -51.92% from its 52-week high of $20.55 and +19.90% up from $8.24, which is 52-week low of the stock.

During the last month, Collegium Pharmaceutical, Inc.’s (COLL) has changed -32.93% and performed -43.38% over the last 6 months. The mean rating score for this stock is at 1.50. This rating scale contains from 1 to 5 with 5 representing a Strong Sell, 1 signifying a Strong Buy and 3 demonstrating a Hold. The Volatility was noted at 7.63% in recent month and observed Weekly Volatility of 5.06%.

Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes abuse-deterrent products that incorporate its DETERx platform technology for the treatment of chronic pain and other diseases. It offers Xtampza, an oral formulation of oxycodone, for the management of pain. The company also develops Onsolis, a transmucosal immediate-release fentanyl film indicated for the management of breakthrough pain in cancer patients 18 years of age and older. The company is also developing COL-195, a hydrocodone for the treatment of chronic pain; COL-172, an oxymorphone for the treatment of chronic pain; COL-196, a morphine formulation to treat pain; and COL-171, a methylphenidate formulation for the treatment of attention deficit hyperactivity disorder. The company was formerly known as Collegium Pharmaceuticals, Inc. and changed its name to Collegium Pharmaceutical, Inc. in October 2003. Collegium Pharmaceutical, Inc. was incorporated in 2002 and is headquartered in Canton, Massachusetts.

BT Group plc (NYSE:BT) finalized the last transaction at value of $20.02. The company maintained volume of 439.25 thousand shares. In past trading day, the stock hit the maximum price of $20.10 and touched to minimum value of $20.00. It has a market cap of $ 39.81B.

Technical Indicators:

As of last trade close, the stock is trading  downside -40.24% from its one year high of $33.50 and moved +4.60% upward from $19.14, which is one year low of the stock.

The stock traded below -0.80% from its 50-day moving average of $20.18. Furthermore, the stock moved -8.30% to its 200-day MA of $ 21.83.

BT Group plc’s (BT) moved with shift of 1.42% in the past week. Over the last three months, the shares of the company have changed -15.67% and performed -13.08% over the last six months. The stock currently has Monthly Volatility of 0.90% and Weekly Volatility of 0.77%.

BT Group plc provides communications services worldwide. The company’s BT Global Services segment offers managed networked IT services to corporate and public sector customers, such as Internet protocol, Ethernet, and Internet virtual private network services; firewalls, Web security, intrusion prevention, and threat monitoring services; collaboration services; contact center services; telehousing and colocation services; and advising, integration, and managed services. Its BT Business segment provides fixed-voice, broadband, mobility, networking, and IT services; fire and security alarm signaling services, surveillance networks, and control room services; directory enquiries, phone book, Website services, operator services, and call handling services; and public, private, and managed payphone services. The company’s BT Consumer segment offers home phone, broadband, TV, mobile, and sports channel services, as well as Wi-Fi services. Its EE segment offers postpaid and prepaid mobile devices, as well as 2G,3G, and 4G mobile services to business customers, MVNO customers, and machine-to-machine devices; sells 4G mobile phones, tablets, and mobile broadband devices; and provides fixed-voice, broadband, and TV services. The company’s BT Wholesale segment provides broadband, Ethernet, media, voice calls, hosted communications, and managed solutions. Its Openreach segment offers fiber-to-the-cabinet, fiber-to-the-premises, wholesale line rental, local loop unbundling, Ethernet access direct, optical spectrum access, flexible co-mingling, passive infrastructure access, and mobile infill infrastructure solutions. BT Group plc retails technology equipment; and provides systems integration, fleet management, payment, audio, video, and Web collaboration services. The company was formerly known as Newgate Telecommunications Limited and changed its name to BT Group plc in September 2001. BT Group plc was incorporated in 2001 and is headquartered in London, the United Kingdom.

 

Leave a Reply

Your email address will not be published. Required fields are marked *